Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed question first answered answering member label
tabling member	label

Search

923137

registered interest
date	13/06/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether the strain of human papilloma virus (HPV) is tested for when an HPV infection is found in women who were offered HPV vaccination; and if so, what were the rates of the different strains found in women who were (1) 13–18 years old, and (2) older than 18.
tabling member printed	The Countess of Mar
uin	HL8601
answer	answer is ministerial correction date of answer 27/06/2018 answer text <p>Human papillomavirus (HPV) testing is performed on specimens collected from some women attending for cervical screening as part of the NHS Cervical Screening Programme (women with borderline or low grade abnormalities, and women in areas piloting HPV primary testing). This test identifies if a high-risk HPV infection is present, but does not identify all the specific HPV types which are present.</p><p>Public Health England has also been monitoring the prevalence of type-specific genital HPV infections through surveys that use specimens from 16-24-year-old sexually active women in England who would have been eligible to receive the HPV vaccine. The latest data, including specimens collected to the end of 2016, has shown a clear reduction in the two high-risk HPV types included in the vaccine and in some other closely related HPV types not included in the vaccine among women aged 16-18 years old. Declines were also seen in women aged 19-21 years old. The prevalence of other high-risk HPV types has not changed.</p> answering member printed Lord O'Shaughnessy question first answered 27/06/2018 14:14:31 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

923138

registered interest
date	13/06/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether colposcopy clinics test all human papilloma virus (HPV) infections for strain types in cohorts of women who were offered HPV vaccination; and if not, why not.
tabling member printed	The Countess of Mar
uin	HL8602
answer	answer is ministerial correction date of answer 27/06/2018 answer text <p>Human papillomavirus (HPV) triage testing is performed in the screening programme on specimens collected from women attending for cervical screening which show borderline or low grade abnormalities. If this test identifies a high-risk HPV infection then the woman will be referred to colposcopy. No further HPV testing is conducted in colposcopy on these specimens to identity the specific HPV types. It is not the role of colposcopy to test HPV infections.</p><p>However, Public Health England does carry out surveillance which has demonstrated a reduction in the HPV types included in the vaccines since the introduction of the national vaccination programme.</p> answering member printed Lord O'Shaughnessy question first answered 27/06/2018 14:12:15 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

923139

registered interest
date	13/06/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what is the rate of ectropions in the cohorts who received human papilloma virus vaccinations.
tabling member printed	The Countess of Mar
uin	HL8603
answer	answer is ministerial correction date of answer 27/06/2018 answer text <p>Data are not collected on the rate of ectropions in the cohorts who received human papillomavirus vaccinations.</p> answering member printed Lord O'Shaughnessy question first answered 27/06/2018 14:12:23 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

923140

registered interest
date	13/06/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what is the efficacy of the human papilloma virus (HPV) vaccination programme in women and girls who may already have had exposure to HPV infection, either naturally or as the result of sexual abuse, prior to receiving that vaccine.
tabling member printed	The Countess of Mar
uin	HL8604
answer	answer is ministerial correction date of answer 27/06/2018 answer text <p>The human papillomavirus (HPV) vaccines have demonstrated very high vaccine efficacy against the vaccine types and related disease in clinical trials when administered to HPV-naïve women (i.e. women with no current or previous vaccine-type HPV infection). However, results from these trials also demonstrated that HPV vaccination of women with a current vaccine-type HPV infection had little or no effect on clearance of the existing infection. There is also some evidence of a slightly reduced vaccine efficacy against pre-cancerous abnormalities among young women currently not infected with HPV but with serological evidence of a previous exposure.</p><p> </p><p>Public Health England has conducted surveillance to monitor the prevalence of type-specific genital HPV infections in 16-24 year old sexually active women in England who would have been eligible to receive the HPV vaccine. The latest data, including specimens collected to the end of 2016, demonstrated a vaccine effectiveness of 82.0% against infections with HPV16/18 among women vaccinated at age 15 years or younger. The vaccine effectiveness in women who would have been vaccinated at age 16 to 18 years old was 48.7%. This suggests that the vaccine works best when given to young girls before they are exposed to HPV. However it also shows that older girls still benefit from vaccination.</p> answering member printed Lord O'Shaughnessy question first answered 27/06/2018 16:37:27 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

923141

registered interest
date	13/06/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what action they are taking to ensure that the cohort of women who have received human papilloma virus vaccinations are aware that they should still attend cervical smear test appointments.
tabling member printed	The Countess of Mar
uin	HL8605
answer	answer is ministerial correction date of answer 27/06/2018 answer text <p>The human papillomavirus (HPV) vaccination programme states in patient communications that cervical screening (smear tests) will continue to be important whether women have had the HPV vaccine or not. Women aged 25 to 64 who are registered with a general practitioner are automatically invited for cervical screening. This includes women who have had the HPV vaccination as the vaccine does not guarantee completed protection of against all high risk strains of HPV. The importance of cervical screening is also reiterated online on NHS Choices.</p> answering member printed Lord O'Shaughnessy question first answered 27/06/2018 14:12:00 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar